BIO-TECHNE Corp Company Profile
BIO-TECHNE Corp as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Minnesota, United States.
- Country of operation (business address): Value United States.
- Business address: Value 614 MCKINLEY PLACE NE, MINNEAPOLIS, Minnesota, United States.
- Mailing address: Value 614 MCKINLEY PLACE NE, MINNEAPOLIS, Minnesota, 55413, United States.
| Measure | Value |
|---|---|
| Current registered country | Minnesota, United States SEC EDGAR state of incorporation MN |
| Country of operation (business address) | United States |
| Business address | 614 MCKINLEY PLACE NE, MINNEAPOLIS, Minnesota, United States |
| Mailing address | 614 MCKINLEY PLACE NE, MINNEAPOLIS, Minnesota, 55413, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 06-30 |
| Filer category | Large accelerated filer |
| Listed stock (Section 12(b)) | Common Stock, $0.01 par value · TECH · NASDAQ 10-K filed 2026-08-24 cover |
| Shell company | No 10-K filed 2026-08-24 cover |
| Smaller reporting company | No 10-K filed 2026-08-24 cover |
| Emerging growth company | No 10-K filed 2026-08-24 cover |
| Well-known seasoned issuer | Yes 10-K filed 2026-08-24 cover |
| Voluntary filer | No 10-K filed 2026-08-24 cover |
| Current in its reporting | Yes 10-K filed 2026-08-24 cover |
| Former names | TECHNE CORP /MN/ (1995-09-20 to 2014-10-28) |
| First EDGAR filing | 1995-05-10 (10-Q) |
| SEC CIK | 842023 |
| EIN | 411427402 |
| Phone | 612-379-8854 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |